China Plans To Amend Nearly 10 Pharma Regs This Year
This article was originally published in PharmAsia News
Executive Summary
China's State FDA plans to launch new GMP guidelines this year to better ensure drug quality, including raw materials registration that will tighten recording requirements, according to a recent SFDA conference